Latest DrugDevelopment News and Updates : DrugDevelopment updates, DrugDevelopment News , DrugDevelopment around the world

Nishadil

Washington | 11°C (overcast clouds)

The Quiet Revolution: Why Biotech VCs Are Now Spotting Gold in Osteoporosis Treatments

Top story

The Quiet Revolution: Why Biotech VCs Are Now Spotting Gold in Osteoporosis Treatments

In focus

Latest feed

FDA’s Hiring Surge Hits a Wall After DOGE Workforce Cuts

CordenPharma Names Jean‑Luc Herbeaux as New CEO to Lead Its Next Growth Chapter

Vera Therapeutics' Trutakna Achieves Landmark Success in Phase 3 Trial for IgA Nephropathy

Merck's Bold Bet Beyond Keytruda: Forging a Future of Pharmaceutical Innovation

Latest headlines

FDA Approves AstraZeneca’s New Breast‑Cancer Therapy Amid Access Hurdles

FDA Approves AstraZeneca’s New Breast‑Cancer Therapy Amid Access Hurdles

Goyal urges Indian pharma to move beyond generics, focus on R&D at Bharat Health Expo 2026

Goyal urges Indian pharma to move beyond generics, focus on R&D at Bharat Health Expo 2026

Vertex Pharma’s Bold Moves: New Leaders and a Landmark Deal

Vertex Pharma’s Bold Moves: New Leaders and a Landmark Deal

Tyra Biosciences' Stock Soars as Crucial Bladder Cancer Drug Data Looms

Tyra Biosciences' Stock Soars as Crucial Bladder Cancer Drug Data Looms

Teva's Strategic Leap: A Proposed Neuroscience Acquisition Paving the Way for Growth

Teva's Strategic Leap: A Proposed Neuroscience Acquisition Paving the Way for Growth

A Beacon of Hope: Cytokinetics' Myqorzo Delivers Promising Results for Overlooked Heart Condition

A Beacon of Hope: Cytokinetics' Myqorzo Delivers Promising Results for Overlooked Heart Condition

Myqorzo Shines: Cytokinetics' Aficamten Delivers Hope for Non-Obstructive HCM Patients

Myqorzo Shines: Cytokinetics' Aficamten Delivers Hope for Non-Obstructive HCM Patients

Alnylam's Heart-Stopping Ambition: Reshaping Cardiovascular Care at ESC

Alnylam's Heart-Stopping Ambition: Reshaping Cardiovascular Care at ESC

The 'Exercise Pill' Dream Moves Closer: Enveda's ENV-308 Shows Early Promise

The 'Exercise Pill' Dream Moves Closer: Enveda's ENV-308 Shows Early Promise

FDA Greenlights Zenbexus: A New Era for Multiple Myeloma Treatment

FDA Greenlights Zenbexus: A New Era for Multiple Myeloma Treatment

A New Dawn for Multiple Myeloma Patients: FDA Approves Bristol-Myers Squibb's Zenbexus

A New Dawn for Multiple Myeloma Patients: FDA Approves Bristol-Myers Squibb's Zenbexus

The No Surprises Act's Unintended Consequence: A Multi-Billion Dollar Headache for Healthcare

The No Surprises Act's Unintended Consequence: A Multi-Billion Dollar Headache for Healthcare

A Glimmer of Hope: India's Leap in Cervical Cancer Treatment Research

A Glimmer of Hope: India's Leap in Cervical Cancer Treatment Research

ICMR Hands Over Indigenous Cancer and Vaccine Technologies to Indian Pharma Leaders

ICMR Hands Over Indigenous Cancer and Vaccine Technologies to Indian Pharma Leaders

Rare Disease Makers Push Back on Medicare Price‑Cut Pilots

Rare Disease Makers Push Back on Medicare Price‑Cut Pilots

Rare‑Disease Makers Push for Medicare Price‑Cut Exemptions

Rare‑Disease Makers Push for Medicare Price‑Cut Exemptions

Swedish scientists craft antibody that blocks aggressive prostate cancer spread

Swedish scientists craft antibody that blocks aggressive prostate cancer spread

Most-Wanted Fugitive Turns Out to Be a Biotech C‑Level Executive

Most-Wanted Fugitive Turns Out to Be a Biotech C‑Level Executive

Daraxonrasib and the Fight Against Pancreatic Cancer: Hope Meets Hurdles

Daraxonrasib and the Fight Against Pancreatic Cancer: Hope Meets Hurdles

Daroxanrasib and Pancreatic Cancer: A New Hope Amidst Ongoing Hurdles

Daroxanrasib and Pancreatic Cancer: A New Hope Amidst Ongoing Hurdles

Alzheimer's Research: A New Frontier Unlocked at AAIC

Alzheimer's Research: A New Frontier Unlocked at AAIC

The Shifting Sands of Alzheimer's Research: Why Tau and the Blood-Brain Barrier Are Our New Front Lines

The Shifting Sands of Alzheimer's Research: Why Tau and the Blood-Brain Barrier Are Our New Front Lines

AI Meets Quantum Computing: Crafting the Next Generation of Peptides

AI Meets Quantum Computing: Crafting the Next Generation of Peptides

Vertex Pharmaceuticals Makes a Major Play, Acquiring Crinetics in a Near-$5 Billion Deal

Vertex Pharmaceuticals Makes a Major Play, Acquiring Crinetics in a Near-$5 Billion Deal

Biotech Power Play: Vertex's Bold Leap into Endocrine Therapies

Biotech Power Play: Vertex's Bold Leap into Endocrine Therapies

Breakthrough Strategy to Tackle Antibiotic‑Resistant Superbugs

Breakthrough Strategy to Tackle Antibiotic‑Resistant Superbugs

A $10 Billion Shake-Up: Vertex Pharmaceuticals to Acquire Crinetics in Major Cash Deal

A $10 Billion Shake-Up: Vertex Pharmaceuticals to Acquire Crinetics in Major Cash Deal

DxVx Takes Center Stage at BIO USA, Forging Global Alliances for Breakthrough Therapies

DxVx Takes Center Stage at BIO USA, Forging Global Alliances for Breakthrough Therapies

The AI Revolution in Biotech: Anthropic's Impact on Our Health Future

The AI Revolution in Biotech: Anthropic's Impact on Our Health Future

A Bipartisan Push? Republican Lawmakers Tackle Clinical Trial Diversity

A Bipartisan Push? Republican Lawmakers Tackle Clinical Trial Diversity

A New Dawn: Roche's Landmark Drug Redefines Hope for KRAS-Driven Lung Cancer Patients

A New Dawn: Roche's Landmark Drug Redefines Hope for KRAS-Driven Lung Cancer Patients

Arcturus Therapeutics Charts a Bold New Course with Thermo Fisher Alliance

Arcturus Therapeutics Charts a Bold New Course with Thermo Fisher Alliance

Abivax’s Obefazimod Shows Promising Safety in Late‑Stage Ulcerative Colitis Maintenance Study

Abivax’s Obefazimod Shows Promising Safety in Late‑Stage Ulcerative Colitis Maintenance Study

A New Dawn in Lymphoma Treatment: AbbVie's Epkinly Shows Remarkable Promise

A New Dawn in Lymphoma Treatment: AbbVie's Epkinly Shows Remarkable Promise

The New Frontier of Drug Development: U.S. and China Race for Clinical Trial Supremacy

The New Frontier of Drug Development: U.S. and China Race for Clinical Trial Supremacy

The Race for Clinical Trial Dominance: United States vs. China

The Race for Clinical Trial Dominance: United States vs. China

A Promising Antiviral Steps Up Against Deadly Mosquito‑Borne Illnesses

A Promising Antiviral Steps Up Against Deadly Mosquito‑Borne Illnesses

AbbVie Takes the Leap: Why the $2.5 B Buy‑out of Apogee Therapeutics Could Redefine Immunology

AbbVie Takes the Leap: Why the $2.5 B Buy‑out of Apogee Therapeutics Could Redefine Immunology

Load more